A major international analysis of 2,313 patients, median age 71, found that giving an IV clot-busting drug before mechanical clot removal modestly increases brain-bleeding risk compared with ...

Leqembi is currently approved for the treatment of early Alzheimer disease and is administered by IV infusion once every 2 weeks. Findings showed that treatment with the weekly SC formulation resulted ...